Nuwellis Corp (NUWE): Enterprise Value to EBITDA Ratio
The quotes provided below demonstrate the EV/EBITDA of Nuwellis, Inc. (NUWE), which stands at 0.00. Nuwellis, Inc. (NUWE) specializes in developing devices for regulating water balance in patients with kidney and heart pathologies, the exclusivity of which provides a market advantage in pricing power. Device assembly is delegated to US contractors under strict engineering supervision, while the current strategy focuses on increasing wholesale shipments of replaceable modules to the hospital sector.
Comprehensive metric breakdowns and analytics for Nuwellis Inc (NUWE)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
NUWE - Net Financial Result|Projected Future Earnings Nuwellis, Inc.|NUWE - Price to Earnings Ratio|Forward P/E Multiple nuwellis.com|NUWE - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc.|NUWE - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Nuwellis|NUWE - Earnings per share for the trailing year|Quarterly EPS earnings growth nuwellis.com|NUWE - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Nuwellis, Inc.
- sales volume and revenue indicators:
Analysis of all company metrics:Nuwellis Inc NUWE
The EV/EBITDA valuation multiple for capital-intensive businesses determines the company's value, including net debt, relative to its operating profit. Analyzing this chart allows for the filtering of market noise, capturing the current value of 0.00 as a marker of financial stability. For Nuwellis, Inc. (NUWE), this metric is critical, as it reflects the ability to generate cash flow amid the gradual modernization of Aquadex systems without radical technological leaps.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Inc - EV/EBITDA Multiple|Company Value to EBITDA tactilemedical.com|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Outset Medical|ELMD (Electromed) - EV/EBITDA Multiple|LENSAR, Inc (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio Profound Medical PROF|EV/EBITDA Multiple BDMD (Baird Medical Investment Holdings)|EV/EBITDA Multiple EDAP TMS S.A. EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (Pulmonx Corp.) - Enterprise Value to EBITDA Ratio|TELA Bio Inc. - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA Sensus Healthcare Inc SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex Medical (ZYXI)|electroCore Medical (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd IINN|ICU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX IRIX|Intelligent Bio Solutions Inc. (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (AINostix)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization profusa.com|Enterprise Value to EBITDA Ratio STRATA Skin Sciences (SSKN)|EV/EBITDA Multiple GCTK|NAOV - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Venus Concept Inc. VERO|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
